PDB Short entry for 1OVI HEADER CYTOKINE 08-JUN-95 1OVI TITLE A THREE DIMENSIONAL MODEL FOR BOVINE INTERFERON-TAU COMPND MOL_ID: 1; COMPND 2 MOLECULE: OVINE INTERFERON TAU; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: OVIFN-TAU SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: OVIS SP.; SOURCE 3 ORGANISM_COMMON: SHEEP; SOURCE 4 TISSUE: EMBRYONIC TROPHOBLAST KEYWDS CYTOKINE EXPDTA THEORETICAL MODEL AUTHOR T.SENDA,S.SAITOH,Y.MITSUI REVDAT 1 15-SEP-95 1OVI 0 JRNL AUTH T.SENDA,S.I.SAITOH,Y.MITSUI,J.LI,R.M.ROBERTS JRNL TITL A THREE-DIMENSIONAL MODEL OF INTERFERON-TAU. JRNL REF J.INTERFERON CYTOKINE RES. V. 15 1053 1995 JRNL REFN US ISSN 1079-9907 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH T.SENDA,Y.MITSUI REMARK 1 TITL CRYSTAL STRUCTURE REFINEMENT OF RECOMBINANT MURINE REMARK 1 TITL 2 INTERFERON-BETA REMARK 1 REF PROTEIN ENG. V. 7 1164 1994 REMARK 1 REFN ASTM PRENE9 UK ISSN 0269-2139 REMARK 1 REFERENCE 2 REMARK 1 AUTH T.SENDA,T.SHIMAZU,S.MATSUDA,G.KAWANO,H.SHIMIZU, REMARK 1 AUTH 2 K.T.NAKAMURA,Y.MITSUI REMARK 1 TITL THREE-DIMENSIONAL CRYSTAL STRUCTURE OF RECOMBINANT REMARK 1 TITL 2 MURINE INTERFERON-BETA REMARK 1 REF EMBO J. V. 11 3193 1992 REMARK 1 REFN ASTM EMJODG UK ISSN 0261-4189 REMARK 1 REFERENCE 3 REMARK 1 AUTH T.SENDA,S.MATSUDA,H.KURIHARA,K.T.NAKAMURA,G.KAWANO, REMARK 1 AUTH 2 H.SHIMIZU,H.MIZUNO,Y.MITSUI REMARK 1 TITL THREE-DIMENSIONAL STRUCTURE OF RECOMBINANT MURINE REMARK 1 TITL 2 INTERFERON-BETA REMARK 1 REF PROC.JPN.ACAD.,SER.B V. 66 77 1990 REMARK 1 REFN ASTM PJABDW JA ISSN 0386-2208 REMARK 1 REFERENCE 4 REMARK 1 AUTH K.IMAKAWA,T.R.HANSEN,P.-V.MALATHY,R.V.ANTHONY, REMARK 1 AUTH 2 H.G.POLITES,K.R.MAROTTI,R.M.ROBERTS REMARK 1 TITL MOLECULAR CLONING AND CHARACTERIZATION OF REMARK 1 TITL 2 COMPLEMENTARY DEOXYRIBONUCLEIC ACIDS CORRESPONDING REMARK 1 TITL 3 TO BOVINE TROPHOBLAST PROTEIN-1: A COMPARISON WITH REMARK 1 TITL 4 OVINE TROPHOBLAST PROTEIN-1 AND BOVINE REMARK 1 TITL 5 INTERFERON-ALPHA II REMARK 1 REF MOL.ENDOCRINOL. V. 3 127 1989 REMARK 1 REFN ASTM MOENEN US ISSN 0888-8809 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NULL REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1OVI COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998 REMARK 5 REMARK 5 RESIDUES 163 - 172 COULD NOT BE MODELED BECAUSE THERE IS REMARK 5 NO BASIS FOR MODELING RELATIVE TO MURINE INTERFERON-BETA. REMARK 6 REMARK 6 HELIX REMARK 6 DETERMINATION METHOD: REMARK 6 KABSCH AND SANDER REMARK 220 REMARK 220 EXPERIMENTAL DETAILS REMARK 220 EXPERIMENT TYPE : THEORETICAL MODELLING REMARK 220 REMARK 220 REMARK: NULL REMARK 225 REMARK 225 THEORETICAL MODEL REMARK 225 THE COORDINATES IN THIS ENTRY REPRESENT A MODEL STRUCTURE. REMARK 225 PROTEIN DATA BANK CONVENTIONS REQUIRE THAT CRYST1 AND REMARK 225 SCALE RECORDS BE INCLUDED, BUT THE VALUES ON THESE REMARK 225 RECORDS ARE MEANINGLESS. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 163 REMARK 465 LYS A 164 REMARK 465 MET A 165 REMARK 465 GLY A 166 REMARK 465 GLY A 167 REMARK 465 ASP A 168 REMARK 465 LEU A 169 REMARK 465 ASN A 170 REMARK 465 SER A 171 REMARK 465 PRO A 172 REMARK 999 REMARK 999 CROSS REFERENCE TO SEQUENCE DATABASE REMARK 999 REMARK 999 SEQUENCE REMARK 999 REFERENCE REMARK 999 DATABASE: GENBANK REMARK 999 ENTRY_NAME: SHPOTPIB REMARK 999 REMARK 999 C-TERMINAL RESIDUES 163 - 172 NOT INCLUDED IN THE MODEL. DBREF 1OVI A 1 172 UNP P28169 INTB_SHEEP 24 195 SEQADV 1OVI THR A 163 UNP P28169 ARG 186 CONFLICT SEQRES 1 A 172 CYS TYR LEU SER GLN ARG LEU MET LEU ASP ALA ARG GLU SEQRES 2 A 172 ASN LEU ARG LEU LEU ASP ARG MET ASN ARG LEU SER PRO SEQRES 3 A 172 HIS SER CYS LEU GLN ASP ARG LYS ASP PHE GLY LEU PRO SEQRES 4 A 172 GLN GLU MET VAL GLU GLY ASP GLN LEU GLN GLU ALA GLN SEQRES 5 A 172 ALA PHE CYS VAL LEU TYR GLU MET LEU GLN GLN SER PHE SEQRES 6 A 172 ASN LEU PHE HIS THR GLU ARG SER SER ALA ALA TRP ASN SEQRES 7 A 172 THR THR LEU LEU GLU GLN LEU CYS THR GLY LEU GLN GLN SEQRES 8 A 172 GLN LEU GLU ASP LEU ASP THR CYS ARG GLY PRO VAL MET SEQRES 9 A 172 GLY GLU LYS ASP SER GLU LEU GLY LYS MET ASP PRO ILE SEQRES 10 A 172 VAL THR VAL LYS LYS TYR PHE GLN GLY ILE HIS PHE TYR SEQRES 11 A 172 LEU LYS GLU LYS GLU TYR SER ASP CYS ALA TRP GLU ILE SEQRES 12 A 172 VAL ARG VAL GLU MET MET ARG ALA LEU SER SER SER THR SEQRES 13 A 172 SER LEU GLN GLU ARG LEU THR LYS MET GLY GLY ASP LEU SEQRES 14 A 172 ASN SER PRO HELIX 1 A SER A 4 MET A 21 1 18 HELIX 2 B ALA A 51 THR A 70 1 20 HELIX 3 C ASN A 78 CYS A 99 1 22 HELIX 4 CD1 ARG A 100 MET A 104 1 5 HELIX 5 CD2 GLY A 105 GLY A 112 1 8 HELIX 6 D MET A 114 LYS A 134 1 21 HELIX 7 E SER A 137 GLU A 160 1 24 SSBOND 1 CYS A 1 CYS A 99 SSBOND 2 CYS A 29 CYS A 139 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000